Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - tobramycin - nebuliser solution - 300/4 milligram(s)/millilitre - other aminoglycosides; tobramycin

Malta - English - Medicines Authority

forest laboratories uk limited - colistin mesilate sodium 1000000 iu - powder and solvent for solution for infusion or injection

Malta - English - Medicines Authority

hospira uk limited - cilastatin; imipenem - powder for solution for infusion - cilastatin 500 mg; imipenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - cilastatin, imipenem - powder for solution for infusion - cilastatin 500 mg imipenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

accord healthcare limited - colistimethate sodium - powder for solution for injection - colistimethate sodium 1 million iu - antibacterials for systemic use

Malta - English - Medicines Authority

accord healthcare limited - colistimethate sodium - powder for solution for injection - colistimethate sodium 2 million iu - antibacterials for systemic use

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with pseudomonas aeruginosa . safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (fev 1 ) <25% or >75% predicted, or patients colonized with burkholderia cepacia [see clinical studies (14)]. tobramycin inhalation solution is contraindicated in patients with a known hypersensitivity to any aminoglycoside. risk summary aminoglycosides can cause fetal harm. published literature reports that use of streptomycin, an aminoglycoside, can cause total, irreversible, bilateral congenital deafness when administered to a pregnant woman [see warnings and precautions (5.5)]. although there are no available data on tobramycin inhalation solution use in pregna

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (includes 4.6% overage).; imipenem monohydrate 560mg equivalent to 500 mg imipenem. (includes 4.6% overage).;   - powder for infusion - 500mg/500mg - active: cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (includes 4.6% overage). imipenem monohydrate 560mg equivalent to 500 mg imipenem. (includes 4.6% overage).   excipient: sodium bicarbonate

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - tigecycline - injection, powder, lyophilized, for solution - 53mg - tigecycline 50 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

milpharm limited - meropenem trihydrate - pdr for soln inj/inf - 500 grams - carbapenems